Risperdal Consta Medicare Reimbursement Set At 95% Of AWP
Executive Summary
Johnson & Johnson's injectable antipsychotic Risperdal Consta (risperidone) will be reimbursed at 95% of AWP effective April 1 under an update to the Medicare Hospital Outpatient Prospective Payment System